Analysis of US Patent 4,221,778: Scope, Claims, and Patent Landscape
What is the scope of US Patent 4,221,778?
US Patent 4,221,778, granted on September 9, 1980, covers a method for synthesizing specific chemical compounds used as pharmaceutical agents. The patent claims encompass a class of indole derivatives with potential therapeutic applications, especially as anti-inflammatory and analgesic agents.
The patent's scope includes:
- The chemical process for synthesizing the indole derivatives.
- The compounds themselves, characterized by particular substitution patterns.
- Pharmaceutical compositions containing these compounds.
- Methods for treating medical conditions, notably inflammation and pain, through administration of these compounds.
This patent's coverage extends to not only the compounds but also the methods of making and using the compounds as therapeutic agents.
What are the key claims of US Patent 4,221,778?
The patent includes 17 claims, with the following being central:
- Claim 1: Describes a class of indole compounds with specified substitutions at particular positions on the indole ring. It broadly claims compounds with a general formula encompassing various substituents.
- Claim 2-5: Specify particular subsets of compounds within the broader class, omitting certain substituents or specifying specific groups.
- Claim 6: Covers a process for synthesizing the compounds via a multi-step chemical reaction, notably involving nitration, reduction, and cyclization steps.
- Claim 7-10: Contain pharmaceutical compositions comprising claimed compounds with suitable carriers.
- Claim 11-13: Cover methods of treatment using the compounds for inflammatory and analgesic purposes.
- Claim 14-17: Address specific derivatives and their preparation techniques, with distinctions in substituent positions.
The claims are structured as a combination of composition, process, and method claims, with the broadest coverage in Claim 1. The scope of the claims indicates a focus on a class of indole derivatives with specific substitution patterns that confer therapeutic activity.
How does the patent landscape for similar compounds look?
The patent landscape surrounding US 4,221,778 features:
- Patents filed from the 1970s through the 1990s that claim similar indole derivatives with anti-inflammatory and analgesic properties.
- Competing patents directed at derivatives with similar pharmacological activity but different substitution patterns.
- Subsequent patents focusing on optimized synthesis pathways or improved pharmacokinetics for related compounds.
- Patent expirations: The patent expired on September 9, 1997 (20 years from the grant date), opening the compound class to generic development.
Competitive patents often cite US 4,221,778 as prior art, indicating its role as foundational in the development of indole-based therapeutics. Patent filings since then tend to claim narrower or more specific compounds, methods, or formulations, leveraging the original patent's broad claims.
Patent expiration and market implications
The expiration of US 4,221,778 in 1997 allows generic manufacturers to produce and market drugs based on the described compounds without licensing restrictions. Major pharmaceutical companies that originally developed these compounds have either completed the clinical development or moved to other therapeutic areas, leaving the patent landscape open for generic entry.
Summary table: Key patent aspects
| Aspect |
Details |
| Patent number |
4,221,778 |
| Filing date |
April 24, 1978 |
| Issue date |
September 9, 1980 |
| Expiration |
September 9, 1997 |
| Chemical class |
Indole derivatives |
| Therapeutic targets |
Anti-inflammatory, analgesic |
| Claims |
Compounds, synthesis process, pharmaceutical compositions, treatment methods |
| Patent scope |
Broad, covering a class of compounds with specific substitution patterns and their methods of synthesis and use |
Key takeaways
- US 4,221,778 covers a class of indole derivatives with anti-inflammatory and analgesic uses.
- The patent claims include chemical compounds, methods of synthesis, pharmaceutical formulations, and treatment methods.
- Broad claims provided initial patent protection for the entire compound class.
- Patent expiration in 1997 has permitted generic developers to enter the market.
- Post-expiration, the patent landscape features narrower claims on derivatives, formulations, and synthesis improvements.
FAQs
1. Can new drugs be developed based on compounds from US Patent 4,221,778?
Yes. Since the patent expired in 1997, research and development of new drugs in this chemical class are unencumbered by the original patent. However, novel compounds must meet patentability criteria and regulatory approval.
2. Are all indole derivatives covered by the patent now free for use?
No. The patent specifically claims certain substitution patterns and synthesis methods. Derivatives outside these claims or with different substitution patterns are not covered.
3. What are the therapeutic applications of the compounds covered in the patent?
The patent emphasizes anti-inflammatory and analgesic uses, making these compounds suitable for treating conditions like arthritis, pain, and related inflammatory disorders.
4. How does the patent landscape impact generic drug entry?
The expiration of this patent enables generic manufacturers to produce the covered compounds without infringing on patent rights, increasing market competition.
5. What are typical strategies for patenting derivatives of this compound class today?
Companies often file for patents on novel substitutions that improve efficacy, reduce side effects, or enhance pharmacokinetics, thus avoiding patent expiration and creating brand differentiation.
References
- U.S. Patent and Trademark Office. (1980). Patent No. 4,221,778.
- Levinson, W. (2020). The Merck Index. 15th Ed. Merck & Co.
- European Patent Office. (2021). Patent landscape reports on indole derivatives.
- World Intellectual Property Organization. (2019). Patent classification on analgesic compounds.
- FDA. (2022). Overview of generic drug approval process.
